dapagliflozin (Compound)

Synonyms:Dapagliflozin, 461432-26-8, BMS-512148, Forxiga, Farxiga, BMS 512148, (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, UNII-1ULL0QJ8UC, (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, 1ULL0QJ8UC, CHEMBL429910, CHEBI:85078, Dapagliflozin [USAN:INN], BMS512148, (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol, Forxiga (TN), CHEMBL3125458, (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol, (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol, Dagagflozin, (1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-D-glucitol, BMS5121458, C-aryl glucoside, 6, Tube101, Dapagliflozin (USAN/INN), 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol, SCHEMBL157820, GTPL4594, BDBM20880, DTXSID20905104, EX-A005, LYN-045, BCPP000265, AMY18541, AOB87300, ZINC3819138, BDBM50448923, CD0219, MFCD13182359, s1548, AKOS005145763, BCP9000583, BL-0052, CCG-229917, CS-0781, DB06292, EX-7214, NCGC00250402-09, AC-24699, BD164346, HY-10450, A25150, C22193, D08897, 432D268, Q409898, J-500392, BRD-K58160573-001-01-3, BRD-K58160573-001-05-4, 1-[3-(beta-D-Glucopyranosyl)-6-chlorobenzyl]-4-ethoxybenzene, D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-, (2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol, (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol, (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol;BMS-512148, (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol

Pubchem:PUBCHEM:9887712

Id:81cc33fd-1765-570e-975d-b0135e006c73

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View dapagliflozin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for dapagliflozin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with dapagliflozin.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 04304 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04304; PubChem_CID:9887712, FILE=drugcentral_drug_04304.json)
	dapagliflozin (9c123175-2524-46b4-b92f-0cdf47cc7591) Collection (Entity type)	Metadatata for dapagliflozin
	dapagliflozin indication Chronic heart failure Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin bioactivity Probable glucose sensor protein SLC5A4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin indication Diabetes Mellitus, Non-Insulin-Dependent Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin indication Chronic Kidney Insufficiency Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dapagliflozin bioactivity Sodium/glucose cotransporter 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin bioactivity Sodium/myo-inositol cotransporter 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin indication Diabetes Mellitus, Insulin-Dependent Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	dapagliflozin bioactivity Sodium/glucose cotransporter 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG